R&D Activities Coupled with Driving Factors Globally is Expected to Propel the Growth of the Esomeprazole Sodium Market

The global esomeprazole sodiums market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The key driving factor for global esomeprazole sodiums market growth is an increase in the number of instances of gastroesophageal reflux disease (GERD) caused by excessive stomach acid production. GERD is a disorder in which the stomach's digestive acid comes into contact with the esophagus, resulting in discomfort known as heartburn. Heartburn can resemble the early symptoms of heart disease, and if a person experience chest discomfort in the jaw or shoulder, are nervous, or have a minor headache,  they should seek emergency medical attention. In the US, the prevalence of GERD is estimated to be between 18% and 28%.

Browse the full report description “Global Esomeprazole Sodium Market Size, Share & Trends Analysis Report, By Dosage(Tablets, Capsules, and Others), By Application (Gastro-Oesophageal Reflux Disease, Duodenal Ulcers, and Others), By Distribution ( Hospital and Clinic Pharmacies, and Online) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/esomeprazole-sodium-market 

North America is anticipated to hold prominent share in the global esomeprazole sodium market. Changes in lifestyle and eating habits are driving factors in the region's residents' stomach acid problems. Peptic ulcer disease affects around 4.6 million people in the US each year, according to a Medscape publication (WebMD LLC), with an estimated 10% of the population showing signs of a duodenal ulcer at some point. H pylori infection causes 90% of duodenal ulcers and 70% to 90% of stomach ulcers. With the usage of popular drugs such as Esomeprazole sodium, early signs and diagnosis can help prevent the disease from arising, adding to the growth of the esomeprazole sodium market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Dosage Class
• By Application
• By Distribution

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including Anuja Healthcare Ltd., AstraZeneca, Cemex Pharma Pvt. Ltd., Dr. Reddy Laboratories Ltd., and Jubilant Pharma Pvt. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Esomeprazole Sodiums Market Report Segment

By Dosage 

• Tablets 
• Capsules 
• others

By Application

• Gastro-OesophagealReflux Disease
• Duodenal Ulcers 
• Others

By Distribution 

• Hospitals and Clinical 
• Online 

Global Esomeprazole Sodiums Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/esomeprazole-sodium-market